Skip to main content
PMC home page
Archives of Disease in Childhood logoLink to Archives of Disease in Childhood
. 1976 Jun;51(6):445–448. doi: 10.1136/adc.51.6.445

Clinical experience with an oral anticoagulant in children.

U Carpentieri, Q X Nghiem, L C Harris
PMCID: PMC1546023  PMID: 942237

Abstract

Nineteen cardiac patients were given warfarin sodium to prevent thrombosis and embolism. Empirical dosage resulted in long hospital stays to obtain a stable therapeutic prothrombin time. Using a dosage of 0 therefore 5-0 therefore 7 mg/kg, therapeutic levels were achieved in a much shorter time. When prothrombin time was excessive, it was successfully reduced with vitamin K or plasma. A haematoma in one case and haematuria in another were easily controlled. Warfarin sodium appears to be appropriate and effective for children requiring anticoagulants within the above dosage limits and with meticulous follow-up.

Full text

PDF
445

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALEXANDER B. Anticoagulant therapy with coumarin congeners. Action and guidelines. Am J Med. 1962 Nov;33:679–691. doi: 10.1016/0002-9343(62)90246-2. [DOI] [PubMed] [Google Scholar]
  2. Aggeler P. M., O'Reilly R. A., Leong L., Kowitz P. E. Potentiation of anticoagulant effect of warfarin by phenylbutazone. N Engl J Med. 1967 Mar 2;276(9):496–501. doi: 10.1056/NEJM196703022760904. [DOI] [PubMed] [Google Scholar]
  3. Aggeler P. M., O'Reilly R. A. The pharmacological basis of oral anticoagulant therapy. Thromb Diath Haemorrh Suppl. 1966;21:227–256. [PubMed] [Google Scholar]
  4. BARRITT D. W., JORDAN S. C. Anticoagulant drugs in the treatment of pulmonary embolism. A controlled trial. Lancet. 1960 Jun 18;1(7138):1309–1312. doi: 10.1016/s0140-6736(60)92299-6. [DOI] [PubMed] [Google Scholar]
  5. Coon W. W., Willis P. W., 3rd Some aspects of the pharmacology of oral anticoagulants. Clin Pharmacol Ther. 1970 May-Jun;11(3):312–336. doi: 10.1002/cpt1970113312. [DOI] [PubMed] [Google Scholar]
  6. Deykin D. Warfarin therapy. 2. N Engl J Med. 1970 Oct 8;283(15):801–803. doi: 10.1056/NEJM197010082831508. [DOI] [PubMed] [Google Scholar]
  7. Kazmier F. J., Spittell J. A., Jr Coumarin drug interactions. Mayo Clin Proc. 1970 Apr;45(4):249–255. [PubMed] [Google Scholar]
  8. Koch-Weser J. Bioavailability of drugs (first of two parts). N Engl J Med. 1974 Aug 1;291(5):233–237. doi: 10.1056/NEJM197408012910505. [DOI] [PubMed] [Google Scholar]
  9. O'Reilly R. A., Aggeler P. M. Determinants of the response to oral anticoagulant drugs in man. Pharmacol Rev. 1970 Mar;22(1):35–96. [PubMed] [Google Scholar]
  10. O'Reilly R. A., Aggeler P. M. Studies on coumarin anticoagulant drugs. Initiation of warfarin therapy without a loading dose. Circulation. 1968 Jul;38(1):169–177. doi: 10.1161/01.cir.38.1.169. [DOI] [PubMed] [Google Scholar]
  11. Robinson D. S., Sylwester D. Interaction of commonly prescribed drugs and warfarin. Ann Intern Med. 1970 Jun;72(6):853–856. doi: 10.7326/0003-4819-72-6-853. [DOI] [PubMed] [Google Scholar]
  12. Weser J. K., Sellers E. Drug interactions with coumarin anticoagulants. 2. N Engl J Med. 1971 Sep 2;285(10):547–558. doi: 10.1056/NEJM197109022851005. [DOI] [PubMed] [Google Scholar]
  13. Wessler S. Anticoagulant therapy--1974. JAMA. 1974 May 6;228(6):757–761. doi: 10.1001/jama.228.6.757. [DOI] [PubMed] [Google Scholar]
  14. Wright I. S. Recent developments in antithrombotic therapy. Ann Intern Med. 1969 Oct;71(4):823–831. doi: 10.7326/0003-4819-71-4-823. [DOI] [PubMed] [Google Scholar]

Articles from Archives of Disease in Childhood are provided here courtesy of BMJ Publishing Group

RESOURCES